A G-tract element in apoptotic agents-induced alternative splicing

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Alternative splicing generates protein diversity from a single pre-mRNA.
• Dysregulation of alternative splicing is implicated in various diseases.

Purpose of the Study:

• To investigate the molecular mechanisms by which apoptotic agents regulate alternative splicing.
• To identify specific sequence elements involved in this regulation.

Main Methods:

• Targeted mutagenesis to identify critical sequences.
• Gene transfer assays to assess functional significance.
• RT-PCR to screen for responsive genes in the human genome.

Main Results:

• Ro-31-8220 (Ro), an apoptotic agent, decreased the cell growth-promoting Bcl-xL splice variant.
• A 16-nucleotide G-tract element (Gt16) was identified as critical for this regulation.
• The Gt16 element conferred Ro-responsiveness to a heterologous gene.
• Okadaic acid inhibited the Ro-induced splicing changes in a dose-dependent manner.
• A group of genes containing similar G-tract elements were identified as responsive to Ro and retinoic acid.

Conclusions:

• The G-tract element (Gt16) is a key regulator of alternative splicing induced by apoptotic agents.
• This regulatory mechanism impacts genes involved in cell growth and death.
• The findings suggest a novel pathway for controlling cell fate through alternative splicing.